Wilson Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Wilson Asset Management's EW Position: Q3 2026 in Review
Wilson Asset Management reduced its Edwards Lifesciences (EW) stake by 16% in Q3 2026, selling an estimated $2.08M and leaving 121,533 shares worth $10.5M. The position accounts for 2.99% of the portfolio, ranked #12.
Wilson Asset Management first reported a position in EW in Q4 2022 and has held it in 16 quarters since. The position peaked at $24.2M in Q1 2024. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Wilson Asset Management held 121,533 shares of Edwards Lifesciences worth $10.5M as of Q3 2026.
- Wilson Asset Management sold 23,385 Edwards Lifesciences shares in Q3 2026, an estimated $2.08M.
- Edwards Lifesciences made up 2.99% of Wilson Asset Management's portfolio in Q3 2026, its #12 holding.
- Wilson Asset Management first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 16 quarters since.
- Wilson Asset Management's Edwards Lifesciences position peaked at $24.2M in Q1 2024.
- 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Wilson Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.